James F Oliviero III Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James F Oliviero III.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James F Oliviero III. James F Oliviero III is a Chief Financial Officer in KERYX BIOPHARMACEUTICALS INC ($KERX) and a Vice President Finance in KERYX BIOPHARMACEUTICALS INC ($KERX) and a Vice President, Finance in KERYX BIOPHARMACEUTICALS INC ($KERX) and a CEO and President in Checkpoint Therapeutics, Inc. ($CKPT) and a CEO, President and Director in Checkpoint Therapeutics, Inc. ($CKPT).
Address: C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK 10022 NY
Companies in which James F Oliviero III is an Insider
Checkpoint Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James F Oliviero III: CEO, President and Director, CEO and President
Holdings: 3,202,000 shares
Current Value: $32,020,000
Latest Transaction: Feb 05 2021
$CKPT Market Capitalization: $216.41M
$CKPT Previous Close: $10.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KERYX BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James F Oliviero III: Chief Financial Officer, Vice President, Finance, Vice President Finance
Holdings: 209,406 shares
Current Value: $1,120,322
Latest Transaction: Jul 08 2015
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James F Oliviero III
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO, President and ... | Sell | S | 3.42 | 48,790 | 166,745 | 3,153,210 | 3.2 M to 3.2 M (-1.52 %) |
| Feb 05 2021 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO, President and ... | Sell | S | 3.51 | 70,000 | 245,525 | 3,202,000 | 3.3 M to 3.2 M (-2.14 %) |
| Feb 25 2020 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO, President and ... | Grant | A | 0.00 | 598,000 | 0 | 2,733,000 | 2.1 M to 2.7 M (+28.01 %) |
| Jan 25 2019 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO, President and ... | Grant | A | 0.00 | 485,000 | 0 | 2,135,000 | 1.7 M to 2.1 M (+29.39 %) |
| Feb 01 2018 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO and President | Grant | A | 0.00 | 325,000 | 0 | 1,650,000 | 1.3 M to 1.7 M (+24.53 %) |
| Dec 19 2016 | CKPT | Checkpoint Therape ... | Oliviero James F III | CEO and President | Grant | A | 0.00 | 325,000 | 0 | 1,325,000 | 1000 K to 1.3 M (+32.50 %) |
| Jul 08 2015 | KERX | KERYX BIOPHARMACEU ... | Oliviero James F III | Chief Financial Off ... | Sell | S | 9.61 | 1,943 | 18,672 | 209,406 | 211.3 K to 209.4 K (-0.92 %) |